PT1380301E - Combinação farmacêutica compreendendo etinilestradiol e drospirenona para utilização como contraceptivo - Google Patents

Combinação farmacêutica compreendendo etinilestradiol e drospirenona para utilização como contraceptivo Download PDF

Info

Publication number: PT1380301E
Authority: PT; Portugal
Prior art keywords: drospirenone; ethinylstradiol; contraceptive; combination; component composition
Prior art date: 1999-08-31

Application number

PT03017743T

Other languages

English (en)

Inventor

Jurgen Hilmann

Ralph Lipp

Wolfgang Heil

Renate Heithecker

Original Assignee

Bayer Schering Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-31

Filing date

2000-08-31

Publication date

2009-03-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26153359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1380301(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-08-31 Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag

2009-03-30 Publication of PT1380301E publication Critical patent/PT1380301E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Dermatology (AREA)
Hematology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT03017743T 1999-08-31 2000-08-31 Combinação farmacêutica compreendendo etinilestradiol e drospirenona para utilização como contraceptivo PT1380301E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US38627499A	1999-08-31	1999-08-31
EP99202826		1999-08-31

Publications (1)

Publication Number	Publication Date
PT1380301E true PT1380301E (pt)	2009-03-30

Family

ID=26153359

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PT03017743T PT1380301E (pt)	1999-08-31	2000-08-31	Combinação farmacêutica compreendendo etinilestradiol e drospirenona para utilização como contraceptivo
PT05076943T PT1598069E (pt)	1999-08-31	2000-08-31	Combinação farmacêutica de etinilestradiol e drospirenona para utilização como um contraceptivo
PT00953387T PT1214076E (pt)	1999-08-31	2000-08-31	Combinacao farmaceutica de etinilestradiol e drospirenona para utilizacao como um contraceptivo

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
PT05076943T PT1598069E (pt)	1999-08-31	2000-08-31	Combinação farmacêutica de etinilestradiol e drospirenona para utilização como um contraceptivo
PT00953387T PT1214076E (pt)	1999-08-31	2000-08-31	Combinacao farmaceutica de etinilestradiol e drospirenona para utilizacao como um contraceptivo

Country Status (26)

Country	Link
EP (4)	EP2044941A1 (pt)
JP (2)	JP4354667B2 (pt)
KR (2)	KR100857344B1 (pt)
AT (3)	ATE429231T1 (pt)
AU (4)	AU780330B2 (pt)
BG (1)	BG66114B1 (pt)
BR (1)	BR0014159A (pt)
CY (3)	CY1108990T1 (pt)
CZ (1)	CZ300514B6 (pt)
DE (5)	DE122009000007I2 (pt)
DK (3)	DK1598069T3 (pt)
EE (1)	EE05128B1 (pt)
ES (3)	ES2319750T3 (pt)
HK (1)	HK1047247B (pt)
HR (1)	HRP20070188B1 (pt)
HU (1)	HU227207B1 (pt)
IL (1)	IL148339A0 (pt)
ME (2)	ME00329B (pt)
NO (1)	NO326860B1 (pt)
NZ (1)	NZ517845A (pt)
PL (1)	PL199028B1 (pt)
PT (3)	PT1380301E (pt)
RS (3)	RS50262B2 (pt)
SI (3)	SI1214076T1 (pt)
TW (1)	TWI276436B (pt)
WO (1)	WO2001015701A1 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2319750T3 (es) *	1999-08-31	2009-05-12	Bayer Schering Pharma Aktiengesellschaft	Composicion farmaceutica que comprende etinilestradiol y drospirenona para usar como anticonceptivo.
EE05533B1 (et) *	2000-01-18	2012-04-16	Schering Aktiengesellschaft	Farmatseutiline kompositsioon ja preparaat, mis sisaldab mikroniseeritud drospirenooni ja strogeeni ning nende kasutamine
JO2334B1 (en) *	2000-01-18	2006-06-28	باير شيرنغ فارما اكتنجيسيلشافت	Drospirenone for hormone replacement therapy
JP5350572B2 (ja) *	2000-12-20	2013-11-27	バイエルファーマアクチエンゲゼルシャフト	シクロデキストリン−ドロスピレノン封入複合体
EP1216713A1 (en)	2000-12-20	2002-06-26	Schering Aktiengesellschaft	Compositions of estrogen-cyclodextrin complexes
PL372055A1 (en) *	2002-04-26	2005-07-11	Schering Aktiengesellschaft	Treatment of hypertension in women receiving hormone replacement therapy
US7786101B2 (en)	2002-11-05	2010-08-31	Bayer Schering Pharma Ag	Cardiovascular protection using anti-aldosteronic progestins
MY142989A (en) *	2004-03-10	2011-02-14	Bayer Schering Pharma Ag	Stabilised supersaturated solids of lipophilic drugs
EP1748756B1 (en) *	2004-03-10	2009-04-29	Bayer Schering Pharma Aktiengesellschaft	Compositions comprising drospirenone molecularly dispersed
MY151322A (en) *	2004-04-30	2014-05-15	Bayer Ip Gmbh	Management of breakthrough bleeding in extended hormonal contraceptive regimens
EP1625849A1 (en) *	2004-08-09	2006-02-15	Liconsa, Liberacion Controlada de Sustancias Activas, S.A.	Pharmaceutical composition comprising drospirenone and ethynylestradiol
EP1871363A4 (en) *	2005-03-30	2009-01-21	Genpharm Inc	COMBINED STAGE PROCESS FOR PHARMACEUTICAL COMPOSITIONS
UY29527A1 (es)	2005-05-13	2006-12-29	Schering Ag	Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
EP1767194A1 (de) *	2005-06-09	2007-03-28	Helm AG	Verfahren zur Herstellung von Adsorbaten des Drospirenons
CN101489563A (zh) *	2006-07-06	2009-07-22	拜耳先灵医药股份有限公司	用于避孕和预防先天性畸形风险的药物制剂
US8617597B2 (en)	2006-07-06	2013-12-31	Bayer Intellectual Property Gmbh	Pharmaceutical composition containing a tetrahydrofolic acid
CA2662956A1 (en) *	2006-09-16	2008-03-20	Bayer Schering Pharma Aktiengesellschaft	Oral modified release formulations
EP1900359A1 (en) *	2006-09-16	2008-03-19	KAIROSmed GmbH	Oral modified release formulations containing drospirenon and 8-prenylnaringenin for use in female contraception
MX2009010763A (es) *	2007-04-05	2009-10-28	Bayer Schering Pharma Ag	NUEVO REGIMEN DE DROSPIRENONA/17ß-ESTRADIOL, PRODUCTO FARMACEUTICO COMBINADO Y CONJUNTO DE ELEMENTOS (KIT) PARA SU APLICACION.
HUP0700826A3 (en) *	2007-12-20	2010-03-29	Richter Gedeon Nyrt	Coated tablet containing drospirenone and process for producing the same
TW200942242A (en) *	2008-03-10	2009-10-16	Rolf Schurmann	New drospirenone/17β-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
TW200946542A (en) *	2008-03-10	2009-11-16	Vladimir Hanes	New drospirenone/17β-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
WO2009138224A1 (en) *	2008-05-14	2009-11-19	Helm Ag	Pharmaceutical composition comprising drospirenone
DE102008037025C5 (de)	2008-08-08	2016-07-07	Jesalis Pharma Gmbh	Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
EP2398461A1 (en)	2009-02-18	2011-12-28	Bayer Pharma Aktiengesellschaft	Formulation comprising drospirenone for subcutaneous or intramuscular administration
UY32836A (es)	2009-08-12	2011-03-31	Bayer Schering Pharma Ag	Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
MX356702B (es) *	2010-04-15	2018-06-11	Bayer Ip Gmbh	Formas de dosificación sólidas orales con dosis muy bajas para la hrt.
AR081670A1 (es)	2010-06-29	2012-10-10	Leon Farma Sa Lab	Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en)	2010-07-28	2020-12-01	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en)	2010-07-28	2022-06-07	Laboratorios Leon Farma Sa	Synthetic progestogens and pharmaceutical compositions comprising the same
US9603860B2 (en)	2010-07-28	2017-03-28	Laboratorios Leon Farma Sa	Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
IT202100008834A1 (it)	2021-04-08	2022-10-08	Ind Chimica Srl	Processo per la preparazione di drospirenone come polvere fine tramite duplice cambio di forma cristallina
WO2023152658A1 (en)	2022-02-10	2023-08-17	Lupin Limited	Slow release drospirenone tablet composition
US20250186337A1 (en) *	2022-03-01	2025-06-12	Chemo Research, S.L.	Chewable oral contraceptive

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2652761C2 (de)	1976-11-16	1985-11-21	Schering AG, 1000 Berlin und 4709 Bergkamen	15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3051167C3 (de) *	1979-01-24	1994-11-24	Minnesota Mining & Mfg	Fluorierte Alkohole
DE3051166C2 (en)	1980-06-11	1990-10-18	Schering Ag, 1000 Berlin Und 4709 Bergkamen, De	Compsns. for contraception or treatment of gynaecological disorders
DE3347125A1 (de)	1983-12-22	1985-07-11	Schering AG, 1000 Berlin und 4709 Bergkamen	Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
US4727064A (en) *	1984-04-25	1988-02-23	The United States Of America As Represented By The Department Of Health And Human Services	Pharmaceutical preparations containing cyclodextrin derivatives
EP0209403B1 (en) *	1985-07-15	1991-10-23	Research Development Corporation of Japan	Process for preparing ultrafine particles of organic compounds
DE3916112A1 (de)	1989-05-16	1990-11-22	Schering Ag	Dihydrospirorenon als antiandrogen
DE4227989A1 (de)	1992-08-21	1994-06-09	Schering Ag	Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DK95093D0 (da) *	1993-08-20	1993-08-20	Novo Nordisk As	Farmaceutisk formulering indeholdende et hormon
ZA939566B (en) *	1993-12-21	1994-08-11	Applied Analytical Ind Inc	Method for dry blend compression od medicaments.
DE4344462C2 (de) *	1993-12-22	1996-02-01	Schering Ag	Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) *	1994-03-30	1995-10-05	Schering Ag	Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE4429374C1 (de) *	1994-08-12	1996-02-01	Jenapharm Gmbh	Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
NZ293606A (en) *	1994-09-22	1998-06-26	Akzo Nobel Nv	Preparation of pharmaceutical dosage units of a steroidal progestogen by mixing with water and granulating the solution
DE19525017A1 (de) *	1995-06-28	1997-01-02	Schering Ag	Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US5922349A (en) *	1995-09-28	1999-07-13	Schering Aktiengesellschaft	Hormone replacement therapy method and hormone dispenser
DE19540253C2 (de) *	1995-10-28	1998-06-04	Jenapharm Gmbh	Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
AU726091B2 (en) *	1996-07-26	2000-11-02	Wyeth	Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
WO1998004267A1 (en) *	1996-07-26	1998-02-05	American Home Products Corporation	Progestin/estrogen oral contraceptive
BR9710565A (pt) *	1996-07-26	1999-08-17	American Home Prod	Contraceptivo oral
DE19633685C1 (de)	1996-08-12	1997-10-09	Schering Ag	Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
DE19651000A1 (de)	1996-12-01	1998-06-04	Schering Ag	Oxyiminopregnancarbolactone
ES2319750T3 (es) *	1999-08-31	2009-05-12	Bayer Schering Pharma Aktiengesellschaft	Composicion farmaceutica que comprende etinilestradiol y drospirenona para usar como anticonceptivo.
EE05533B1 (et) *	2000-01-18	2012-04-16	Schering Aktiengesellschaft	Farmatseutiline kompositsioon ja preparaat, mis sisaldab mikroniseeritud drospirenooni ja strogeeni ning nende kasutamine

2000
- 2000-08-31 ES ES03017743T patent/ES2319750T3/es not_active Expired - Lifetime
- 2000-08-31 ME MEP-2008-360A patent/ME00329B/me unknown
- 2000-08-31 RS RS14502A patent/RS50262B2/sr unknown
- 2000-08-31 EP EP08015966A patent/EP2044941A1/en not_active Withdrawn
- 2000-08-31 DE DE200912000007 patent/DE122009000007I2/de active Active
- 2000-08-31 KR KR1020027002795A patent/KR100857344B1/ko not_active Expired - Lifetime
- 2000-08-31 IL IL14833900A patent/IL148339A0/xx active IP Right Grant
- 2000-08-31 DE DE60042089T patent/DE60042089D1/de not_active Expired - Lifetime
- 2000-08-31 DK DK05076943T patent/DK1598069T3/da active
- 2000-08-31 SI SI200030308T patent/SI1214076T1/xx unknown
- 2000-08-31 WO PCT/IB2000/001213 patent/WO2001015701A1/en not_active Ceased
- 2000-08-31 HU HU0202500A patent/HU227207B1/hu unknown
- 2000-08-31 PT PT03017743T patent/PT1380301E/pt unknown
- 2000-08-31 DE DE60041421T patent/DE60041421D1/de not_active Expired - Lifetime
- 2000-08-31 EE EEP200200110A patent/EE05128B1/xx not_active IP Right Cessation
- 2000-08-31 PT PT05076943T patent/PT1598069E/pt unknown
- 2000-08-31 DK DK03017743T patent/DK1380301T3/da active
- 2000-08-31 ME MEP-360/08A patent/MEP36008A/xx unknown
- 2000-08-31 HR HRP20070188AA patent/HRP20070188B1/hr not_active IP Right Cessation
- 2000-08-31 AT AT05076943T patent/ATE429231T1/de active
- 2000-08-31 EP EP05076943A patent/EP1598069B1/en not_active Revoked
- 2000-08-31 JP JP2001519915A patent/JP4354667B2/ja not_active Expired - Lifetime
- 2000-08-31 CZ CZ20020615A patent/CZ300514B6/cs not_active IP Right Cessation
- 2000-08-31 NZ NZ51784500A patent/NZ517845A/xx not_active IP Right Cessation
- 2000-08-31 DK DK00953387T patent/DK1214076T3/da active
- 2000-08-31 PT PT00953387T patent/PT1214076E/pt unknown
- 2000-08-31 BR BR0014159-3A patent/BR0014159A/pt not_active Application Discontinuation
- 2000-08-31 AU AU65895/00A patent/AU780330B2/en not_active Expired
- 2000-08-31 PL PL354406A patent/PL199028B1/pl unknown
- 2000-08-31 DE DE200912000006 patent/DE122009000006I2/de active Active
- 2000-08-31 ES ES05076943T patent/ES2325589T3/es not_active Expired - Lifetime
- 2000-08-31 KR KR1020077013070A patent/KR101019361B1/ko not_active Expired - Lifetime
- 2000-08-31 DE DE60006692T patent/DE60006692T2/de not_active Expired - Lifetime
- 2000-08-31 AT AT00953387T patent/ATE254464T1/de active
- 2000-08-31 AT AT03017743T patent/ATE420648T1/de active
- 2000-08-31 RS YU14502A patent/RS50262B/sr unknown
- 2000-08-31 EP EP00953387A patent/EP1214076B1/en not_active Revoked
- 2000-08-31 HK HK02109000.7A patent/HK1047247B/en not_active IP Right Cessation
- 2000-08-31 SI SI200031034T patent/SI1598069T1/sl unknown
- 2000-08-31 EP EP03017743A patent/EP1380301B1/en not_active Revoked
- 2000-08-31 ES ES00953387T patent/ES2211580T3/es not_active Expired - Lifetime
- 2000-08-31 SI SI200031021T patent/SI1380301T1/sl unknown
- 2000-08-31 RS RSP-2009/0134A patent/RS20090134A/sr unknown
- 2000-11-16 TW TW089124254A patent/TWI276436B/zh not_active IP Right Cessation
2002
- 2002-02-19 NO NO20020801A patent/NO326860B1/no not_active IP Right Cessation
2005
- 2005-05-13 AU AU2005202046A patent/AU2005202046B9/en not_active Expired
2006
- 2006-11-23 BG BG109749A patent/BG66114B1/bg unknown
2009
- 2009-01-22 AU AU2009200247A patent/AU2009200247B2/en not_active Expired
- 2009-03-02 JP JP2009048381A patent/JP2009143959A/ja active Pending
- 2009-04-14 CY CY20091100446T patent/CY1108990T1/el unknown
- 2009-07-22 CY CY20091100784T patent/CY1109252T1/el unknown
- 2009-09-25 CY CY2009015C patent/CY2009015I1/el unknown
2010
- 2010-10-01 AU AU2010226924A patent/AU2010226924A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DK1380301T3 (da)	2009-04-20
IL148339A0 (en)	2002-09-12
HK1047247B (en)	2004-07-23
ATE420648T1 (de)	2009-01-15
DE60041421D1 (de)	2009-03-05
WO2001015701A1 (en)	2001-03-08
NO20020801D0 (no)	2002-02-19
PT1214076E (pt)	2004-04-30
AU780330B2 (en)	2005-03-17
SI1214076T1 (en)	2004-06-30
SI1380301T1 (sl)	2009-06-30
KR20020040798A (ko)	2002-05-30
EP1214076B1 (en)	2003-11-19
AU2009200247A1 (en)	2009-02-19
BR0014159A (pt)	2002-05-07
MEP36008A (hr)	2011-02-10
ES2325589T3 (es)	2009-09-09
DE122009000006I2 (de)	2012-03-22
HU227207B1 (en)	2010-11-29
CY2009015I2 (el)	2014-02-12
ME00329B (me)	2011-05-10
DE122009000007I1 (de)	2009-05-07
HUP0202500A2 (en)	2002-10-28
TWI276436B (en)	2007-03-21
PT1598069E (pt)	2009-07-20
CZ300514B6 (cs)	2009-06-03
AU2005202046B2 (en)	2008-11-20
DE60042089D1 (de)	2009-06-04
EP1598069A3 (en)	2006-04-05
JP2003508441A (ja)	2003-03-04
EE200200110A (et)	2003-06-16
HRP20070188B1 (hr)	2015-06-19
KR101019361B1 (ko)	2011-03-07
YU14502A (sh)	2006-01-16
KR100857344B1 (ko)	2008-09-05
CZ2002615A3 (cs)	2002-08-14
NZ517845A (en)	2004-12-24
JP2009143959A (ja)	2009-07-02
PL199028B1 (pl)	2008-08-29
EP2044941A1 (en)	2009-04-08
HK1047247A1 (en)	2003-02-14
AU2009200247B2 (en)	2010-07-01
DE122009000007I2 (de)	2011-07-21
CY2009015I1 (el)	2014-02-12
CY1109252T1 (el)	2014-07-02
AU6589500A (en)	2001-03-26
DE122009000006I1 (de)	2009-05-07
RS50262B2 (sr)	2018-10-31
CY1108990T1 (el)	2014-02-12
JP4354667B2 (ja)	2009-10-28
HK1082432A1 (en)	2006-06-09
HUP0202500A3 (en)	2004-04-28
SI1598069T1 (sl)	2009-10-31
EP1380301B1 (en)	2009-01-14
NO326860B1 (no)	2009-03-02
DK1598069T3 (da)	2009-07-06
RS20090134A (sr)	2009-11-10
AU2010226924A1 (en)	2010-10-28
EP1380301A1 (en)	2004-01-14
DE60006692T2 (de)	2004-09-23
RS50262B (sr)	2009-07-15
EP1214076A1 (en)	2002-06-19
DK1214076T3 (da)	2004-02-23
KR20070067248A (ko)	2007-06-27
BG66114B1 (bg)	2011-05-31
ES2211580T3 (es)	2004-07-16
ES2319750T3 (es)	2009-05-12
EE05128B1 (et)	2009-02-16
AU2005202046A1 (en)	2005-06-09
DE60006692D1 (de)	2003-12-24
NO20020801L (no)	2002-04-26
HRP20070188A2 (en)	2007-07-31
ATE254464T1 (de)	2003-12-15
HK1061968A1 (en)	2004-10-15
EP1598069B1 (en)	2009-04-22
EP1598069A2 (en)	2005-11-23
PL354406A1 (pl)	2004-01-12
AU2005202046B9 (en)	2008-12-11
ATE429231T1 (de)	2009-05-15

Publication	Publication Date	Title
PT1380301E (pt)	2009-03-30	Combinação farmacêutica compreendendo etinilestradiol e drospirenona para utilização como contraceptivo
ES2558030T3 (es)	2016-02-01	Método anticonceptivo oral multifásico de ciclo prolongado
RU2005140938A (ru)	2007-07-10	Дроспиренон для гормональной заместительной терапии
EA200600964A1 (ru)	2006-10-27	Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина
ATE216241T1 (de)	2002-05-15	Sehr niedrigdosiertes orales kontrazeptiv mit weniger menstruationsblutungen und verzögerter wirkung
AP2001002054A0 (en)	2001-03-31	Use of biogenic estrogen sulfamates for hormone replacement therapy.
AP2003002763A0 (en)	2003-03-31	Controlled release formulations for oral administration
RU2010114825A (ru)	2011-10-20	Фармацевтическая композиция, способ ее получения и многофазный фармацевтический препарат для ингибирования овуляции у млекопитающего
CA1300017C (en)	1992-05-05	Composition for preventing osteoporosis
HRP20090256T1 (en)	2009-06-30	Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method
US5026706A (en)	1991-06-25	Method for treating dysuria using naftopidil
RU2225714C2 (ru)	2004-03-20	Новый набор противозачаточных средств
PT1121109E (pt)	2006-09-29	Formulacao bifasica contendo tramadol
NO20072687L (no)	2007-11-13	Farmasoytisk prevensjonspreparat
AU692155B2 (en)	1998-06-04	Method and composition for treatment of osteoporosis
RU2009140372A (ru)	2011-05-10	Новый режим с дроспиреноном/17b-эстрадиолом, фармацевтический комбинированный продукт и набор для выполнения этого режима